TNFa and IL-6 promote ex-vivo proliferation of lineage-committed human regulatory T cells
Frontiers in Immunology(2021)
Abstract
Treg therapy is being tested in clinical trials in transplantation and autoimmune diseases, however, the impact of inflammation on Tregs is unclear. In this study, we challenged human Tregs ex-vivo with pro-inflammatory cytokines, TNFα and IL-6. These cytokines enhanced Treg proliferation induced by anti-CD3 and anti-CD28 or CD28 superagonist (CD28SA) while maintaining high expression of FOXP3 and HELIOS, demethylated FOXP3 enhancer, and low expression of cytokines IFNg, IL-4 and IL-17. Blocking TNF receptor signaling using etanercept or deletion of TNF receptor 2 using CRISPR/Cas9 blunted Treg proliferation and attenuated FOXP3 and HELIOS expression, revealing the importance of TNFR2 signaling in Treg proliferation and lineage stability. The robust proliferation induced by CD28SA with IL-6 and TNFα may be adopted for the expansion of therapeutic Tregs. Metabolomics analysis showed that Tregs expanded with CD28SA plus cytokines had more active glycolysis and oxidative phosphorylation, increased energy production, and higher antioxidant potential. Finally, CD28SA plus cytokine-expanded Tregs had comparable suppressive activity in vitro and in vivo in a humanized mouse model of graft-versus-host-disease when compared to Tregs expanded using the conventional protocol. These results demonstrate that human Tregs positively respond to proinflammatory cytokines with enhanced proliferation without compromising their lineage identity or function.
### Competing Interest Statement
QT is a co-founder and scientific advisor of Sonoma Biotherapeutics. QT, NS and FV are coinventors of a patent on manufacturing Tregs based on results from this work. The remaining authors have no relevant competing interests to disclose.
* aCD3/28
: anti-CD3 and anti-CD28 dynabeads
CD28SA
: CD28 super agonist
CNS
: Central Nervous System
FAO
: Fatty acid oxidation
FOXP3
: Forkhead box protein
P3 GVHD
: Graft-versus-host-disease
GSH
: glutathione
GSSG
: glutathione disulfide
LTα
: lymphotoxin α
NSG
: NOD.Cg-PrkdcscidIl2rgtm1Wjl/SzJ
OXPHOS
: oxidative phosphorylation
RORγT
: Retinoic acid-related orphan receptor γT
Tconv
: conventional CD4+ T cell
Teff
: effector T cell
TNFR1
: Tumor necrosis factor receptor 1
TNFR2
: Tumor necrosis factor receptor 2
TNFSF
: Tumor necrosis factor superfamily
TCR
: T cell receptor
TSDR
: Treg-specific demethylated region
MoreTranslated text
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined